SVRA Stock Price, Savara Inc Quote, Chart

Market Summary

USD4.45-0.27

Market Closed

-5.72%

SVRA Stock Price

View Fullscreen

SVRA RSI Chart

SVRA Valuation

Market Cap

614.9M

Price/Earnings (Trailing)

-9.54

Price/Sales (Trailing)

2.7K

EV/EBITDA

-10.65

Price/Free Cashflow

-10.24

SVRA Price/Sales (Trailing)

SVRA Profitability

EBT Margin

-26821.79%

Return on Equity

-52.92%

Return on Assets

-40.74%

Free Cashflow Yield

-9.76%

SVRA Fundamentals

SVRA Revenue

Revenue (TTM)

257.0K

SVRA Earnings

Earnings (TTM)

-64.5M

Earnings Growth (Yr)

-92.73%

Earnings Growth (Qtr)

-26.38%

Breaking Down SVRA Revenue

Last 7 days

-4.5%

Last 30 days

-10.3%

Last 90 days

-10.5%

Trailing 12 Months

73.8%

How does SVRA drawdown profile look like?

SVRA Financial Health

Current Ratio

14.9

Debt/Equity

0.22

Debt/Cashflow

-2.26

SVRA Investor Care

Shares Dilution (1Y)

21.15%

Diluted EPS (TTM)

-0.37

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2020	22.3M	14.9M	7.6M	257.0K
2019	0	0	0	29.6M
2018	15.0M	22.3M	0	0
2017	7.7M	0	0	0
2016	140.5K	227.0K	313.5K	400.0K
2015	0	0	0	54.0K
2010	0	0	0	489.0K

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Savara Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 21, 2024	erickson anne	sold (taxes)	-1,832	4.81	-381	chief business officer
Dec 28, 2023	lowrance david l	sold	-47,131	4.7131	-10,000	chief financial officer
Dec 28, 2023	pauls matthew	gifted	-	-	-19,000	chief executive officer
Dec 28, 2023	pauls matthew	sold	-395,900	4.7131	-84,000	chief executive officer
Dec 28, 2023	elam nevan c	sold	-442,291	4.7131	-93,843	-
Dec 28, 2023	elam nevan c	acquired	69,721	1.29695	53,758	-
Dec 15, 2023	lowrance david l	gifted	-	-	-20,000	chief financial officer
Dec 14, 2023	lowrance david l	acquired	-	-	160,000	chief financial officer
Dec 14, 2023	pauls matthew	sold (taxes)	-488,076	4.45	-109,680	chief executive officer
Dec 14, 2023	ramsay david a	acquired	-	-	22,500	-

Which funds bought or sold SVRA recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	AWM Investment Company, Inc.	new	-	498,000	498,000	0.06%
May 16, 2024	CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	added	411	308,526	378,410	-%
May 16, 2024	COMERICA BANK	new	-	1,120	1,120	-%
May 16, 2024	JANE STREET GROUP, LLC	added	42.00	143,376	427,528	-%
May 15, 2024	UBS ASSET MANAGEMENT AMERICAS LLC	new	-	86,154	86,154	-%
May 15, 2024	OPTIONS SOLUTIONS, LLC	new	-	551,132	551,132	0.31%
May 15, 2024	WELLINGTON MANAGEMENT GROUP LLP	added	34.9	4,157,530	13,840,300	-%
May 15, 2024	BARCLAYS PLC	reduced	-37.02	-194,000	388,000	-%
May 15, 2024	Altium Capital Management LP	added	0.15	383,200	6,648,300	2.63%
May 15, 2024	Frazier Life Sciences Management, L.P.	unchanged	-	1,120,000	19,920,000	0.84%

Are Funds Buying or Selling SVRA?

Are funds buying SVRA calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own SVRA

No. of Funds

Unveiling Savara Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Apr 12, 2024	bain capital life sciences fund ii, l.p.	9.99%	14,565,457	SC 13D/A
Feb 14, 2024	zambon spa	3.46%	4,680,000	SC 13G/A
Feb 14, 2024	venrock healthcare capital partners ii, l.p.	2.6%	3,500,000	SC 13G/A
Feb 13, 2024	caxton corp	0.3%	353,441	SC 13G/A
Feb 13, 2024	prudential financial inc	7.23%	0	SC 13G
Feb 08, 2024	jennison associates llc	6.5%	8,815,358	SC 13G
Feb 07, 2024	adage capital partners gp, l.l.c.	5.64%	7,637,930	SC 13G/A
Feb 01, 2024	farallon capital partners, l.p.	1.9%	2,542,599	SC 13G/A
Jan 31, 2024	blackrock inc.	5.4%	7,261,530	SC 13G
Jul 26, 2023	growth equity opportunities 17, llc	18.1%	24,471,264	SC 13D/A

Recent SEC filings of Savara Inc

View All Filings

Date Filed	Form Type	Document
May 09, 2024	10-Q	Quarterly Report
May 09, 2024	S-3	S-3
Apr 26, 2024	ARS	ARS
Apr 26, 2024	DEF 14A	DEF 14A
Apr 26, 2024	DEFA14A	DEFA14A
Apr 23, 2024	4	Insider Trading
Apr 12, 2024	SC 13D/A	13D - Major Acquisition
Apr 12, 2024	8-K	Current Report
Apr 12, 2024	PRE 14A	PRE 14A
Mar 29, 2024	3	Insider Trading

Peers (Alternatives to Savara Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
MRNA	50.9B	6.8B	28.49%	6.05%	-8.53	7.44	-64.45%	-224.75%
HILS	22.5B	216.3K	-0.77%	465779.94%	-2.5K	104.0K	-	-8.13%
ALNY	18.9B	2.0B	2.79%	-21.33%	-56.9	9.43	75.20%	68.82%
BMRN	14.7B	2.5B	-14.30%	-15.94%	71.65	5.96	13.74%	186.89%
INCY	12.8B	3.8B	8.33%	-10.25%	17.2	3.4	8.58%	129.81%
MID-CAP
BBIO	5.6B	107.9M	20.58%	115.45%	-10.31	48.09	54.84%	-28.31%
APLS	5.0B	524.1M	-13.99%	-52.79%	-12.02	9.57	394.93%	39.61%
AXSM	3.6B	251.0M	9.96%	-0.29%	-12.28	14.5	73.58%	-86.73%
ARWR	3.1B	240.7M	9.94%	-31.73%	-6.53	12.77	-1.03%	-213.43%
ACAD	2.4B	813.8M	-14.08%	-36.34%	-1.4K	3	56.43%	98.83%
SMALL-CAP
CPRX	1.9B	411.3M	3.06%	35.16%	29.91	4.73	60.38%	-34.49%
NVAX	1.8B	996.6M	234.45%	75.34%	-4.58	1.83	-26.66%	65.49%
CRBP	480.9M	881.7K	21.10%	351.81%	-14.25	481.06	-77.61%	33.36%
INO	310.9M	4.9M	8.40%	53.85%	-2.49	63.89	-54.97%	48.23%
IBIO	17.1M	2.1M	4.76%	108.64%	-0.74	7.61	-13.45%	69.54%

Savara Inc News

Latest updates

Savara Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)														(In Thousands)
Description	(%) Q/Q	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2018Q2	2018Q1	2017Q1	2016Q4	2016Q3	2016Q2	2016Q1	2015Q4	2010Q4
Revenue	-	-	-	-	-	-	-	-	0.00	0.00	0.00	-	-	-	-
Operating Expenses	17.9%	13.00	11.00	9.00	16.00	32.00	12.00	-	-	-	-	-	-	-	-
S&GA Expenses	-48.1%	3.00	5.00	3.00	3.00	3.00	2.00	2.00	-	-	-	-	-	-	-
Interest Expenses	-	-	-	-	-	1.00	0.00	0.00	-	-	-	-	-	-	-
Income Taxes	-	-	-	-	-	-	-0.28	-4.55	-0.24	-	-	-	-	-	-
Earnings Before Taxes	-	-	-	-9.39	-15.42	-31.72	-11.59	-31.40	-5.21	-1.95	-3.23	-2.05	-	-	-
Net Income	-24.2%	-13.74	-11.06	-9.39	-15.42	-31.72	-11.59	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-10.9%	158	178	182	120	129	140	148	157	166	177	187	196	208	98.00	109	115	120	136	141	147	148
Current Assets	-11.9%	146	166	170	108	118	129	137	145	155	165	175	183	195	85.00	96.00	103	107	124	108	114	108
Cash Equivalents	-36.8%	17.00	27.00	28.00	23.00	34.00	52.00	120	95.00	79.00	34.00	45.00	41.00	56.00	23.00	35.00	47.00	35.00	50.00	18.00	17.00	26.00
Net PPE	-8.1%	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Goodwill	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	19.00	19.00	27.00
Liabilities	-2.0%	36.00	37.00	36.00	32.00	31.00	32.00	31.00	30.00	30.00	32.00	32.00	31.00	33.00	33.00	33.00	31.00	33.00	35.00	34.00	35.00	46.00
Current Liabilities	-7.4%	10.00	11.00	9.00	6.00	5.00	6.00	5.00	4.00	16.00	15.00	11.00	6.00	7.00	8.00	8.00	6.00	8.00	11.00	8.00	9.00	9.00
Long Term Debt	0.3%	26.00	26.00	26.00	26.00	26.00	26.00	26.00	26.00	13.00	17.00	21.00	25.00	25.00	25.00	-	-	-	-	-	-	-
LT Debt, Current	-	-	-	-	-	-	-	-	-	13.00	8.00	4.00	-	-	-	-	-	-	-	-	-	-
LT Debt, Non Current	-100.0%	-	26.00	26.00	26.00	26.00	26.00	26.00	26.00	13.00	17.00	21.00	25.00	25.00	25.00	-	-	-	-	-	-	-
Shareholder's Equity	-13.2%	122	140	147	88.00	98.00	108	117	127	136	144	155	165	175	64.00	77.00	84.00	87.00	102	107	113	102
Retained Earnings	-5.2%	-413	-393	-377	-360	-349	-338	-328	-317	-308	-300	-289	-278	-267	-257	-243	-232	-223	-207	-176	-163	-141
Additional Paid-In Capital	0.4%	536	534	525	449	448	447	446	446	445	445	444	443	442	321	320	316	311	310	283	276	244
Shares Outstanding	0.0%	138	138	135	114	114	114	153	153	153	114	153	152	77.00	-	-	-	-	-	-	-	-
Float	-	-	-	-	410	-	-	-	159	-	-	-	180	-	-	-	116	-	-	-	78.00	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-32.3%	-20,644	-15,600	-13,200	-10,300	-12,000	-8,651	-8,162	-9,316	-8,425	-9,363	-8,927	-12,194	-9,597	-12,300	-6,705	-7,752	-13,079	-9,946	-11,413	-12,905	-10,859
Share Based Compensation	65.8%	2,257	1,361	995	958	864	561	450	456	574	853	690	771	946	439	1,931	1,175	1,931	1,149	1,146	1,147	1,000
Cashflow From Investing	64.3%	10,793	6,571	-56,586	-1,006	-6,095	-59,211	32,996	25,195	53,665	-1,268	12,983	-3,432	-77,739	-381	-6,861	18,080	-1,785	16,751	6,590	-14,921	7,320
Cashflow From Financing	-99.4%	49.00	7,895	74,755	104	26.00	1.00	-1.00	88.00	-1.00	6.00	10.00	324	120,466	-	1,827	2,328	-466	25,248	5,708	19,056	4,896

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

SVRA Income Statement

2024-03-31

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating expenses:
Research and development	$ 16,807	$ 8,738
General and administrative	5,636	3,366
Depreciation and amortization	32	8
Total operating expenses	22,475	12,112
Loss from operations	(22,475)	(12,112)
Other income (expense)
Interest income	1,353	765
Foreign currency exchange gain (loss)	(21)	29
Tax credit income	797	761
Total other income, net	2,129	1,555
Net loss	$ (20,346)	$ (10,557)
Net loss per share:
Basic	$ (0.11)	$ (0.07)
Diluted	$ (0.11)	$ (0.07)
Weighted-average common shares outstanding:
Basic	182,550,109	152,781,580
Diluted	182,550,109	152,781,580
Other comprehensive income (loss):
Gain (loss) on foreign currency translation	$ (220)	$ 130
Unrealized gain (loss) on short-term investments	(251)	14
Total comprehensive loss	$ (20,817)	$ (10,413)

SVRA Balance Sheet

2024-03-31

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 16,785	$ 26,585
Short-term investments	126,258	135,734
Prepaid expenses and other current assets	3,144	3,628
Total current assets	146,187	165,947
Property and equipment, net	248	270
In-process R&D	10,712	10,960
Other non-current assets	1,148	387
Total assets	158,295	177,564
Current liabilities:
Accounts payable	2,853	3,504
Accrued expenses and other current liabilities	6,957	7,093
Total current liabilities	9,810	10,597
Long-term liabilities:
Long-term debt	26,416	26,348
Other long-term liabilities	208	247
Total liabilities	36,434	37,192
Commitments and Contingencies (Note 9)
Stockholders’ equity:
Common stock, $0.001 par value, 300,000,000 authorized as of March 31, 2024 and December 31, 2023; 138,176,641 and 138,143,545 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	140	140
Additional paid-in capital	536,178	533,872
Accumulated other comprehensive loss	(742)	(271)
Accumulated deficit	(413,715)	(393,369)
Total stockholders’ equity	121,861	140,372
Total liabilities and stockholders’ equity	$ 158,295	$ 177,564

About Savara Inc

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. is headquartered in Austin, Texas.

CEO	Mr. Matthew Pauls J.D., M.B.A.
WEBSITE	savarapharma.com
INDUSTRY	Biotechnology
EMPLOYEES	28

Savara Inc Frequently Asked Questions

What is the ticker symbol for Savara Inc? What does SVRA stand for in stocks?

SVRA is the stock ticker symbol of Savara Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Savara Inc (SVRA)?

As of Fri May 17 2024, market cap of Savara Inc is 614.94 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SVRA stock?

You can check SVRA's fair value in chart for subscribers.

What is the fair value of SVRA stock?

You can check SVRA's fair value in chart for subscribers. The fair value of Savara Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Savara Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for SVRA so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Savara Inc a good stock to buy?

The fair value guage provides a quick view whether SVRA is over valued or under valued. Whether Savara Inc is cheap or expensive depends on the assumptions which impact Savara Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SVRA.

What is Savara Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, SVRA's PE ratio (Price to Earnings) is -9.54 and Price to Sales (PS) ratio is 2.73 Thousand. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SVRA PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Savara Inc's stock?

In the past 10 years, Savara Inc has provided 0.208 (multiply by 100 for percentage) rate of return.